Articles

Autologous stem cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca
Fondazione Italiana Linfomi (FIL) Onlus, Modena
Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca
Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo
Department of Statistics, Hospital Universitario de Salamanca / IBSAL, Salamanca
Hematology Department, Hospital de la Santa Creu i Sant Pau, José Carreras Leukemia Research Institute and IIB Sant Pau, Barcelona
Department of Hematology, Clínica Universidad de Navarra, IdiSNA, Pamplona
Department of Translational and Precision Medicine, Sapienza University, Rome
Department of Hematology, Son Espases University Hospital, IdISBa, Palma de Mallorca
Department of Hematology, Hospital Clínic de Barcelona, Barcelona
Hematology Department, Hospital Gregorio Marañón / IISGM, Madrid
Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona
Hematology Department, Hospital de Especialidades de Jerez de la Frontera, Cádiz
Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia
Hematology Department, Hospital Universitario Virgen del Rocío, Seville
Hematology Department, Hospital Universitario 12 de Octubre, Madrid
Hematology Department, CIBERONC, Instituto Carlos III, Hospital Universitario y Politécnico La Fe, Valencia
Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino)
Hematology Department, Hospital Universitario Reina Sofía, Cordoba
Department of Translational Research, MD Anderson Cancer Center, Madrid
Division of Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Hematology Department, Hospital La Princesa, Madrid
Department of Hematology, Complejo Hospitalario de León, León
Hematology Department, Hospital Regional, Málaga
Hematology Department, Hospital Universitario Ramón y Cajal, Madrid
Division of Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN)
Division of Hematology, ASST Spedali Civili di Brescia, Brescia
Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander
Department of Hematology, University Hospital Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona
Medical Oncology, CHIMOMO Department, University of Modena and Reggio Emilia, Modena
Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca
Haematologica Early view Mar 24, 2022 https://doi.org/10.3324/haematol.2021.279426